|
PIBF1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.758100E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.503800E-02 |
| Normal-vs-Stage2 |
9.969200E-01 |
| Normal-vs-Stage3 |
1.881150E-03 |
| Normal-vs-Stage4 |
5.916100E-03 |
| Stage1-vs-Stage2 |
2.215600E-01 |
| Stage1-vs-Stage3 |
7.002500E-02 |
| Stage1-vs-Stage4 |
1.547250E-01 |
| Stage2-vs-Stage3 |
3.407500E-02 |
| Stage2-vs-Stage4 |
5.890100E-02 |
| Stage3-vs-Stage4 |
6.662800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.455600E-02 |
| Normal-vs-AfricanAmerican |
4.832300E-02 |
| Normal-vs-Asian |
9.563200E-01 |
| Caucasian-vs-AfricanAmerican |
7.355600E-01 |
| Caucasian-vs-Asian |
4.223800E-01 |
| AfricanAmerican-vs-Asian |
2.922000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.775800E-03 |
| Normal-vs-Female |
1.958240E-01 |
| Male-vs-Female |
1.041630E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.896100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.457970E-01 |
| Normal-vs-Age(61-80Yrs) |
6.300200E-03 |
| Normal-vs-Age(81-100Yrs) |
6.502200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.292800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.245800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.247800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.420840E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.412000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.249600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.731200E-01 |
| Normal-vs-Grade 2 |
6.035200E-01 |
| Normal-vs-Grade 3 |
1.679190E-03 |
| Normal-vs-Grade 4 |
3.85020000004399E-06 |
| Grade 1-vs-Grade 2 |
3.396000E-01 |
| Grade 1-vs-Grade 3 |
2.923600E-03 |
| Grade 1-vs-Grade 4 |
1.011550E-04 |
| Grade 2-vs-Grade 3 |
7.155100E-04 |
| Grade 2-vs-Grade 4 |
6.28280000025683E-07 |
| Grade 3-vs-Grade 4 |
1.337710E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.709400E-01 |
| Normal-vs-ccB subtype |
6.23089999999271E-05 |
| ccA subtype-vs-ccB subtype |
1.96330000035161E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.575900E-02 |
| Normal-vs-N1 |
1.468010E-02 |
| N0-vs-N1 |
1.811350E-01 |
|
|
